How glycobiology can help us treat and beat the COVID-19 pandemic

Mostrar todas las versiones(2)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) emerged during the last months of 2019, spreading throughout the world as a highly transmissible infectious illness designated as COVID-19. Vaccines have now appeared, but the challenges in producing sufficient material and distributing the...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lardone, Ricardo D., Garay, Yohana C., Parodi, Pedro, de la Fuente, Sofia, Angeloni, Genaro, Bravo, Eduardo O., Schmider, Anneke K., Irazoqui, Fernando J.
Formato:	article
Lenguaje:	Inglés
Publicado:	2021
Materias:	Covid 19 SARS-CoV-2 Glycobiology Potential therapies FDA - approved drugs Food and Drug Administration
Acceso en línea:	http://hdl.handle.net/11086/20041 https://www.jbc.org/article/S0021-9258(21)00147-2/fulltext
Aporte de:	Repositorio Digital Universitario (UNC) de Universidad Nacional de Córdoba

Ejemplares similares

How glycobiology can help us treat and beat the COVID-19 pandemic
por: Lardone, Ricardo Dante, et al.
Publicado: (2021)

Intelligent drug development : trials and errors in clinical research /
por: Tansey, Michael
Publicado: (2014)

An overview of biosimilars approvals by thirteen regulatory authorities: A cross national comparison
por: Lacerda da Silva Machado, Fernanda, et al.
Publicado: (2023)

Ethics and the FDA.
por: Fielder, John

Glycobiology of immune responses
por: Rabinovich, G.A., et al.

Glycobiology of immune responses
Publicado: (2012)

[FM approval standards] /
Publicado: (2006)

Manual de investigaciones cl�inicas y farmacol�ogicas /
por: Kerzberg, Eduardo Mario
Publicado: (2008)

Valor terapéutico y precio de los nuevos fármacos comercializados en Argentina:¿valen lo que cuestan?
por: Cañás, Martín, et al.
Publicado: (2019)

Development and approval of combination products a regulatory perspective /
Publicado: (2008)

Valores estacionales de FDN y FDA de hojas de morera tras degradación en diferentes tiempos de incubación en caprinos ruminoflstulados
por: Brem, Juan José, et al.
Publicado: (2024)

Design controls.
por: Bartoo, Grace

Current good manufacturing practices : pharmaceutical, biologics, and medical device regulations and guidance documents. Code of Federal Regulations, title 21 concise desk reference.
por: Allport-Settle, Mindy J.
Publicado: (2009)

Open Glycoscience

Bisphosphonates derived from fatty acids are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase
por: Szajnman, S.H., et al.

Bisphosphonates derived from fatty acids are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase
por: Szajnman, Sergio Hernán, et al.
Publicado: (2003)

Synthesis of heteroaryl 1-thio-β-D-galactofuranosides and evaluation of their inhibitory activity towards a β-D-galactofuranosidase
por: Mariño, K., et al.

Synthesis of heteroaryl 1-thio-β-D-galactofuranosides and evaluation of their inhibitory activity towards a β-D-galactofuranosidase
Publicado: (2005)

Producción y calidad de silaje de soja: evaluación del momento óptimo de confección y del agregado de dosis crecientes de inoculante
por: Guercio, Ana
Publicado: (2025)

Chapter 7 Glycobiology of Trypanosoma cruzi
por: de Lederkremer, R.M., et al.

Chapter 7 Glycobiology of Trypanosoma cruzi
por: Muchnik de Lederkremer, Rosa María, et al.
Publicado: (2009)

Is vernakalant better or not compared with other treatments for conversion acute atrial fibrillation?
por: Conde, D.

Is vernakalant better or not compared with other treatments for conversion acute atrial fibrillation?
Publicado: (2013)

Bisphosphonates derived from fatty acids are potent growth inhibitors of Trypanosoma cruzi
por: Szajnman, S.H., et al.

Bisphosphonates derived from fatty acids are potent growth inhibitors of Trypanosoma cruzi
por: Szajnman, Sergio Hernán, et al.
Publicado: (2001)

Aprovação de empréstimos a governos subnacionais no Brasil: há espaço para comportamento político oportunista?
por: Paulo Roberto Arvate, et al.
Publicado: (2008)

Strategies to Predict Students’ Exam Attendance
por: Villarreal, Gonzalo Luján, et al.
Publicado: (2024)

La sección "Noticias" de la revista Isalud ofrece información accesible y actualizada sobre temas generales
Publicado: (2024)

Brain monoamine content in rats treated with the antidepressants mianserin and amoxapine
por: Cicardo, V.H., et al.

Brain monoamine content in rats treated with the antidepressants mianserin and amoxapine
Publicado: (1983)

Condicionantes socioeconómicos para la aprobación de la primera asignatura de la carrera de medicina
por: Said Rücker, Patricia Beatriz Teresita, et al.
Publicado: (2022)

How Can Network-Pharmacology Contribute to Antiepileptic Drug Development?
por: Di Ianni, Mauricio Emiliano, et al.
Publicado: (2014)

Facts and reflections on COVID-19 and anti-hypertensives drugs
por: Marín, Gustavo Horacio
Publicado: (2020)

Reposicionamiento de fármacos para SARS-CoV-2: nuevos usos para drogas ya aprobadas - COVID 19
por: Cavasotto, Claudio, et al.
Publicado: (2021)

Drug repurposing screening validated by experimental assays identifies two clinical drugs targeting SARS-CoV-2 main protease
por: Prada Gori, Denis Nihuel, et al.
Publicado: (2023)

The handbook of drugs and society /
Publicado: (2016)

Dangerous harvest drug plants and the transformation of indigenous landscapes /
Publicado: (2004)

Evidence-based maintenance of medical equipment : an outcomes-based method of keeping medical equipment safe and reliable /
por: Binseng, Wang
Publicado: (2020)

Generic drug product development specialty dosage forms /
Publicado: (2010)

Alcoholic beverages consumption in the City of Córdoba during the COVID 19 pandemic
por: Trucchia, Silvina, et al.
Publicado: (2021)